IS6686A - Hýdrógel-drifið lyfjaskömmtunarform - Google Patents

Hýdrógel-drifið lyfjaskömmtunarform

Info

Publication number
IS6686A
IS6686A IS6686A IS6686A IS6686A IS 6686 A IS6686 A IS 6686A IS 6686 A IS6686 A IS 6686A IS 6686 A IS6686 A IS 6686A IS 6686 A IS6686 A IS 6686A
Authority
IS
Iceland
Prior art keywords
hydrogel
dosage form
powered dosage
powered
dosage
Prior art date
Application number
IS6686A
Other languages
English (en)
Inventor
Elizabeth Appel Leah
C. Babcock Walter
Arthur Beyerinck Ronald
Brian Chidlaw Mark
John Curatolo William
Thomas Friesen Dwayne
Max Herbig Scott
Govind Thombre Avinash
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS6686A publication Critical patent/IS6686A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS6686A 2000-08-09 2003-01-16 Hýdrógel-drifið lyfjaskömmtunarform IS6686A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22419900P 2000-08-09 2000-08-09
PCT/IB2001/001390 WO2002011702A2 (en) 2000-08-09 2001-08-03 Hydrogel-driven drug dosage form

Publications (1)

Publication Number Publication Date
IS6686A true IS6686A (is) 2003-01-16

Family

ID=22839665

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6686A IS6686A (is) 2000-08-09 2003-01-16 Hýdrógel-drifið lyfjaskömmtunarform

Country Status (30)

Country Link
US (2) US20030086972A1 (is)
EP (1) EP1326587A2 (is)
JP (1) JP2004505907A (is)
KR (1) KR20030024844A (is)
CN (1) CN1461212A (is)
AP (1) AP2001002237A0 (is)
AU (1) AU2002229141A1 (is)
BG (1) BG107538A (is)
BR (1) BR0113067A (is)
CA (1) CA2418907A1 (is)
DO (1) DOP2001000229A (is)
EA (1) EA200300081A1 (is)
EC (1) ECSP034455A (is)
EE (1) EE200300055A (is)
GT (1) GT200100161A (is)
HR (1) HRP20030082A2 (is)
HU (1) HUP0300722A2 (is)
IL (1) IL154012A0 (is)
IS (1) IS6686A (is)
MA (1) MA26939A1 (is)
MX (1) MXPA03001209A (is)
NO (1) NO20030627L (is)
OA (1) OA12365A (is)
PA (1) PA8524901A1 (is)
PE (1) PE20020307A1 (is)
PL (1) PL360658A1 (is)
SV (1) SV2002000586A (is)
TN (1) TNSN01123A1 (is)
UY (1) UY26876A1 (is)
WO (1) WO2002011702A2 (is)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
YU35302A (sh) * 1999-12-23 2005-03-15 Pfizer Products Inc. Dozirani oblik leka sa inicijalnim hidrogelom
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
EP1738751B1 (en) 2001-01-12 2011-05-11 Sun Pharma Advanced Research Company Ltd Spaced drug delivery system
CN1596100A (zh) 2001-09-28 2005-03-16 麦克内尔-Ppc股份有限公司 可食用组合物及含可食用外壳的制剂
WO2003096968A2 (en) * 2002-05-15 2003-11-27 Sun Pharmaceutical Industries Limited Oral osmotic controlled drug delivery system
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8084058B2 (en) 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
KR20120034211A (ko) * 2002-09-20 2012-04-10 안드렉스 랩스 엘엘씨 약제학적 정제
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
WO2004028510A1 (en) * 2002-09-28 2004-04-08 Mcneil-Ppc, Inc. Delayed release dosage forms
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
FR2850576B1 (fr) * 2003-02-05 2007-03-23 Ethypharm Sa Composition comprenant un melange de principes actifs, et procede de preparation
US20060210633A1 (en) * 2003-04-03 2006-09-21 Sun Pharmaceutical Industries Limited Programmed drug delivery system
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
AR040157A1 (es) * 2003-06-06 2005-03-16 Rodriguez Julio Cesar Una formulacion en microgranulos para administracion oral en suspension acuosa
JP2007501217A (ja) * 2003-08-04 2007-01-25 ファイザー・プロダクツ・インク コレステリルエステル転送タンパク質阻害剤を制御放出し、そしてＨＭＧ−ＣｏＡレダクターゼ阻害剤を即時放出する投薬形態
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
WO2006082500A1 (en) * 2005-02-03 2006-08-10 Pfizer Products Inc. Dosage forms providing controlled and immediate release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors
US20060193912A1 (en) * 2005-02-28 2006-08-31 Penwest Pharmaceuticals Co. Controlled release O-desmethylvenlafaxine formulations
WO2006123364A2 (en) * 2005-03-14 2006-11-23 Sun Pharmaceutical Industries Limited Oral drug delivery system providing a coating comprising both a cellulose and a methacrylic acid derivative
EP1858483A4 (en) * 2005-03-16 2009-07-15 Reddys Lab Ltd Dr SYSTEM FOR THE DELIVERY OF MULTIPLE MEDICAMENTS
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
CN100448433C (zh) * 2005-09-21 2009-01-07 广州贝氏药业有限公司 一种克拉霉素肠溶药物组合物
WO2007124372A2 (en) * 2006-04-20 2007-11-01 Transport Pharmaceuticals, Inc. Pharmaceutical formulations for iontophoretic methotrexate delivery
KR20080076382A (ko) * 2007-02-15 2008-08-20 (주)아모레퍼시픽 실로스타졸의 제어방출 제제 및 그 제조방법
KR20100136967A (ko) * 2008-02-15 2010-12-29 썬 파마 어드밴스트 리서치 컴패니 리미티드 파열 효과가 감소된 방출 제어 경구 정제
EA201290315A1 (ru) * 2009-11-09 2012-10-30 Кэпсьюджел Белджиум Нв Носитель для доставки
ES2601884T3 (es) 2010-03-19 2017-02-16 Daiichi Sankyo Company, Limited Procedimiento para mejorar la capacidad de disolución de un anticoagulante
CA2844604C (en) * 2011-08-10 2017-07-18 Daiichi Sankyo Company, Limited Pharmaceutical composition containing ethanediamide derivatives
EP2950822B1 (en) * 2013-01-30 2019-04-24 Daewoong Co., Ltd. Pharmaceutical composition for protecting wounds, providing hemostasis, or preventing adhesion in the gastrointestinal tract
MA41868A (fr) * 2015-04-01 2018-02-06 Spectrum Brands Inc Pastille retard et procédés s'y rapportant
AU2019231699B2 (en) * 2018-03-07 2023-03-09 Andrew Xian Chen Aqueous formulations for insoluble drugs
AR125988A1 (es) * 2021-05-28 2023-08-30 Amgen Inc Formulaciones de apremilast
CN113600179B (zh) * 2021-09-16 2023-07-04 山东博霖环保科技发展有限公司 一种脱硝催化剂及其制备方法
JPWO2023063381A1 (is) * 2021-10-14 2023-04-20

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1025765B (it) * 1974-11-18 1978-08-30 Gastaldi Francesco Essiccatore perfezionato a spruzzo
US4187617A (en) * 1978-12-18 1980-02-12 Becker James J Jr Spray dryer
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4624848A (en) * 1984-05-10 1986-11-25 Ciba-Geigy Corporation Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
US4851232A (en) * 1987-02-13 1989-07-25 Alza Corporation Drug delivery system with means for obtaining desirable in vivo release rate pattern
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5096716A (en) * 1988-09-01 1992-03-17 Alza Corporation Dosage form for administering calcium antagonist nicardipine
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5120548A (en) * 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
JPH05178763A (ja) * 1991-02-19 1993-07-20 Nippon Saafuakutanto Kogyo Kk 難溶解性薬物溶解剤組成物
RO114740B1 (ro) * 1994-05-06 1999-07-30 Pfizer Compozitie cu eliberare controlata, procedeu de obtinere a acesteia si metoda de tratament
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
ID23429A (id) * 1997-07-01 2000-04-20 Pfizer Prod Inc Komposisi-komposisi sertralina yang larut
SK180499A3 (en) * 1997-07-01 2001-08-06 Pfizer Sertraline salts and sustained-release dosage forms of sertraline
DE19747261A1 (de) * 1997-10-25 1999-04-29 Bayer Ag Osmotisches Arzneimittelfreisetzungssystem
US6037346A (en) * 1997-10-28 2000-03-14 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
ID29845A (id) * 1998-10-13 2001-10-18 Pfizer Prod Inc Konsentrat oral sertralina
EP1027888B1 (en) * 1999-02-10 2009-06-10 Pfizer Products Inc. Osmotic system for delivery of solid amorphous dispersions of drugs
US6500459B1 (en) * 1999-07-21 2002-12-31 Harinderpal Chhabra Controlled onset and sustained release dosage forms and the preparation thereof
GT200100039A (es) * 2000-03-16 2001-12-31 Pfizer Inhibidor de la glucogeno fosforilasa.
EP1572163A1 (en) * 2002-12-11 2005-09-14 Pfizer Products Inc. Controlled-release of an active substance into a high fat environment

Also Published As

Publication number Publication date
WO2002011702A3 (en) 2002-11-28
TNSN01123A1 (fr) 2005-11-10
AU2002229141A1 (en) 2002-02-18
JP2004505907A (ja) 2004-02-26
IL154012A0 (en) 2003-07-31
BG107538A (bg) 2003-11-28
EA200300081A1 (ru) 2003-08-28
AP2001002237A0 (en) 2001-09-30
EE200300055A (et) 2004-12-15
EP1326587A2 (en) 2003-07-16
KR20030024844A (ko) 2003-03-26
BR0113067A (pt) 2003-07-01
WO2002011702A2 (en) 2002-02-14
US20040052845A1 (en) 2004-03-18
PE20020307A1 (es) 2002-04-23
HRP20030082A2 (en) 2003-04-30
ECSP034455A (es) 2003-03-10
MXPA03001209A (es) 2003-06-30
OA12365A (en) 2006-05-16
US20030086972A1 (en) 2003-05-08
CN1461212A (zh) 2003-12-10
GT200100161A (es) 2002-03-22
UY26876A1 (es) 2002-03-22
NO20030627D0 (no) 2003-02-07
PL360658A1 (en) 2004-09-20
NO20030627L (no) 2003-04-08
HUP0300722A2 (hu) 2003-11-28
MA26939A1 (fr) 2004-12-20
DOP2001000229A (es) 2002-09-30
PA8524901A1 (es) 2002-04-25
CA2418907A1 (en) 2002-02-14
SV2002000586A (es) 2002-10-24

Similar Documents

Publication Publication Date Title
NL300999I2 (nl) macimorelin
IS6686A (is) Hýdrógel-drifið lyfjaskömmtunarform
DE60038698D1 (de) Hydrogel-gesteuerte dosierungsform
ATE290000T1 (de) Muscarinagonisten
ATE252099T1 (de) Biarylcarboxamide
DE10136334B8 (de) Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser
DK1524266T3 (da) Farmaceutisk sammensætning
ATE312098T1 (de) Thiazinoxazolidinon
ATA2932001A (de) Schneefräse
EE200200420A (et) Linesoliid - kristallivorm II
ATE298751T1 (de) 7-oxopyridoryrimidine
ATE262530T1 (de) Indolochinazolinone
DE10192638T1 (de) Bohrstangenladevorrichtung
AR027931A1 (es) Antitranspirantes
DE50007634D1 (de) Kardioplegieballonkatheter
DE10052925B4 (de) Schaukelbett
DE10085445T1 (de) Drahterodierbearbeitungseinrichtung
DE10195909T1 (de) Viehfüttervorrichtung
AR027982A1 (es) Aril- y heteroarilsulfonatos
DE10195992T1 (de) Oberflächenendbearbeitungsbelag
ATE284887T1 (de) Thienopyrrolidinone
DE10054120B4 (de) Aufsparrendämmelement
DE10195959T1 (de) Bohrspitzenstabilisator
ATA7092001A (de) Skibindungseinstellgerät
AT500246B8 (de) Chokerring